Vaccine Hesitancy Intervention--Provider (VHIP)
NCT01667354 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 491
Last updated 2017-10-13
Summary
The primary aim of this trial is to test the effectiveness of an intervention to train primary care physicians to determine if it leads to decreased parental vaccine hesitancy.
Conditions
- Childhood Vaccination
Interventions
- BEHAVIORAL
-
Academic Detailing
The intervention design is based on "academic detailing," an effective method of changing physician behavior. The aim of the training is effective communication with parents who are hesitant about childhood vaccinations.
Sponsors & Collaborators
-
Seattle Children's Hospital
collaborator OTHER -
Washington State, Department of Health
collaborator OTHER_GOV -
WithinReach
collaborator UNKNOWN -
Kaiser Permanente
lead OTHER
Principal Investigators
-
David Grossman, MD, MPH · Kaiser Permanente
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2013-10-31
- Completion
- 2014-04-30
Countries
- United States
Study Locations
More Related Trials
-
Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China
NCT01025544 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics
NCT03111251 ·Status: COMPLETED ·Phase: NA
-
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)
NCT00289913 ·Status: COMPLETED ·Phase: PHASE4
-
Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso
NCT03614533 ·Status: COMPLETED ·Phase: PHASE2
-
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
NCT00501137 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age
NCT00345579 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA
NCT04636827 ·Status: UNKNOWN ·Phase: PHASE4
-
Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.
NCT00326118 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
NCT00197236 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants
NCT01226953 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
NCT00322335 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
NCT06618196 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.
NCT00345683 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
NCT00441012 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine
NCT02692859 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
NCT03277313 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)
NCT00835380 ·Status: COMPLETED ·Phase: PHASE3
-
First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine
NCT01188512 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immune Response of Different Pediatric Combination Vaccines.
NCT00255047 ·Status: COMPLETED ·Phase: PHASE3
-
Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib
NCT00332566 ·Status: COMPLETED ·Phase: PHASE3
-
Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib
NCT00652951 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
NCT00734565 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children
NCT01428908 ·Status: COMPLETED ·Phase: PHASE3
-
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
NCT00131833 ·Status: COMPLETED ·Phase: PHASE4
-
HPV Vaccine in Postpartum Women
NCT04430907 ·Status: WITHDRAWN